slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 94,051-94,080
Pages 3,683
Rows per page 30
Component
94,051-94,080 of 110,471
03
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
06
Uses a waterfall-bridge style to illustrate revenue growth drivers and headwinds.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
08
The slide uses a three-pillar framework to describe the company's strategic approach to oncology.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
09
The slide uses a grid of cards to present clinical trial names, associated drugs, and key outcomes.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a process diagram to illustrate the mechanism of action and a benefit-chain to explain the clinical advantages of the linker design.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
The slide uses a checkmark/cross comparison matrix to demonstrate the superiority of QCS over IHC.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
19
The slide uses a matrix-like layout to map clinical trials to patient segments. The right-hand side provides a strategic summary of the trial program's design principles.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
24
The slide outlines a hierarchical testing strategy with alpha-exhaustive recycling and gatekeeping.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
32
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
34
The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
41
Waterfall plot shows best change in target lesion size; includes CA-125 response markers.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
42
Waterfall plot shows RECIST v1.1 response criteria. Includes legend for dose levels and callout boxes for clinical outcomes.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
44
The slide highlights the structural design (knob-into-hole) and clinical development pipeline for two specific IO assets.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
45
WCLC conference presentation slide. Includes waterfall plot and summary table of ORR and treatment continuation.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
46
Spider plot (swimmer plot variant) showing individual patient response trajectories.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
47
Waterfall plot shows tumor shrinkage; includes key clinical metrics (ORR, mPFS) and safety/future trial status.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
49
The chart uses a bridge/waterfall structure to show revenue growth drivers.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
50
The slide uses a grid-based layout to organize events by year, with checkmarks indicating completed or high-priority milestones.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
53
The slide uses a grid layout to categorize clinical trials by disease stage and patient population, highlighting established standards of care (SoC) with hatched patterns.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
07
The slide uses a split-screen layout to contrast partnership-based revenue with internal pipeline development.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
10
The slide uses a 'How we did it' process flow at the bottom to explain the underlying methodology.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
20
The slide uses a vertical list format to present the investment thesis.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
22
Includes corporate structure details, shareholder list, and headshots of leadership.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
23
Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
26
The slide outlines a standard clinical trial structure (SAD, Food Effect, MAD) and highlights the competitive advantage of a clean safety profile compared to historical PDE10 inhibitors.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
27
The slide emphasizes the absence of CNS-associated adverse events, which is a key differentiator for this PDE10 inhibitor.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
29
The slide uses a honeycomb/network diagram to represent data integration and processing.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
30
The slide uses a process flow diagram to map specific technical capabilities to stages of drug discovery.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
02
Delivery Hero | Investor Presentation Deck | 54 slidesDelivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations 1 hit
06
Includes a timeline-style progression of profitability milestones.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Problem1 hit